Blockchain Registration Transaction Record

Cardio Diagnostics CEO Discusses AI-Powered Heart Disease Prevention

Cardio Diagnostics CEO Dr. Meesha Dogan discusses AI-powered precision medicine for heart disease prevention on The BioMedWire Podcast. Expansion into India and Medicare reimbursement progress highlighted.

This news matters because cardiovascular disease remains the leading cause of death globally, and early detection is critical for improving outcomes. Cardio Diagnostics' use of AI and epigenetics represents a paradigm shift from reactive to proactive care, potentially enabling earlier interventions and personalized treatment plans. The company's expansion into India and progress with Medicare reimbursement signal that this technology could become widely accessible, impacting millions of patients. For investors, the completion of CPT coding and payment steps, with coverage determination underway, indicates a clear path to market adoption and revenue generation, making this a stock to watch in the precision medicine space.